CASTIGLIONE, VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 1.082
EU - Europa 939
AS - Asia 227
SA - Sud America 7
OC - Oceania 4
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.262
Nazione #
US - Stati Uniti d'America 1.043
IT - Italia 449
GB - Regno Unito 148
IE - Irlanda 126
SG - Singapore 72
CN - Cina 60
DE - Germania 58
UA - Ucraina 46
CA - Canada 37
FI - Finlandia 37
VN - Vietnam 36
HK - Hong Kong 26
SE - Svezia 24
PK - Pakistan 19
RO - Romania 13
FR - Francia 11
AT - Austria 10
IN - India 7
AU - Australia 4
AR - Argentina 3
BD - Bangladesh 3
ES - Italia 3
HU - Ungheria 3
IR - Iran 3
NL - Olanda 3
CH - Svizzera 2
DK - Danimarca 2
MG - Madagascar 2
PE - Perù 2
BR - Brasile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EU - Europa 1
IL - Israele 1
LT - Lituania 1
MX - Messico 1
PL - Polonia 1
RS - Serbia 1
Totale 2.262
Città #
Chandler 181
Dublin 126
Boardman 104
Fairfield 84
San Mateo 82
Cambridge 61
Pisa 51
Rome 47
Wilmington 40
Seattle 38
Singapore 38
Stevenage 38
Portsmouth 36
Ottawa 34
Southend 33
Falls Church 32
Ashburn 30
Florence 30
Helsinki 30
Lawrence 30
Woodbridge 29
Houston 26
Jacksonville 24
Milan 22
Beijing 19
Dong Ket 18
Hong Kong 17
Washington 15
Ann Arbor 14
Buti 14
Livorno 14
London 14
San Diego 14
Redmond 13
Assago 12
Genoa 12
Dearborn 11
Fremont 11
Dallas 10
Islamabad 9
Norwalk 9
Palermo 9
Shanghai 8
West Jordan 8
Bucharest 7
Cascina 7
Central District 7
Lappeenranta 7
Bologna 6
Lucca 6
Zirl 6
Bari 5
Guangzhou 5
Hounslow 5
Hyderabad 5
Iowa City 5
Padova 5
Redwood City 5
Sector 3 5
Acton 4
Albavilla 4
Berlin 4
Brooklyn 4
Frankfurt am Main 4
Melbourne 4
Nuremberg 4
Viareggio 4
Vienna 4
Agordo 3
Amsterdam 3
Birmingham 3
Concordia 3
Custonaci 3
Forlì 3
Lahore 3
Los Angeles 3
Mola di Bari 3
Nanjing 3
Oristano 3
Parma 3
Peshawar 3
Serra 3
Shenzhen 3
Varallo Pombia 3
Veresegyház 3
Barletta 2
Brescia 2
Canzo 2
Castelnuovo di Val di Cecina 2
Catania 2
Chicago 2
Chiswick 2
Concesio 2
Corigliano Calabro 2
Cosenza 2
Denver 2
Dongguan 2
Giulianova 2
Gujranwala 2
Hilden 2
Totale 1.700
Nome #
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 121
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 119
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 95
A simple echocardiographic score to rule out cardiac amyloidosis 87
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 85
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 78
Unveiling a sudden unexplained death case by whole exome sequencing and bioinformatic analysis 77
Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis 72
Myocardial salvage is increased after sympathetic renal denervation in a pig model of acute infarction 71
Healthy hearts at hectic pace: From daily life stress to abnormal cardiomyocyte function and arrhythmias 67
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 64
Treatment of cardiac transthyretin amyloidosis: an update 58
Atrial amyloidosis: mechanisms and clinical manifestations 53
Use of biomarkers to diagnose and manage cardiac amyloidosis 52
Biomarkers for the diagnosis and management of heart failure 51
Molecular autopsy of sudden cardiac death in the genomics era 49
Role of Imaging in Cardiomyopathies 48
Cardiovascular disease and COVID-19: les liaisons dangereuses 47
Biomarkers for the diagnosis and management of heart failure: New frontiers 45
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure 43
The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction 43
Current and emerging drug targets in heart failure treatment 43
Scared to Death: Emotional Stress Causing Fatal Myocardial Infarction With Nonobstructed Coronary Arteries in Women 42
Cardiac magnetic resonance in patients with muscular dystrophies 38
Coronary Artery Anomalies 34
Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure: JACC Review Topic of the Week 33
The Left Ventricular Mass-to-Strain Ratio: Enough to Differentiate ATTR From AL Cardiac Amyloidosis? 32
The unbearable underreporting of comorbidities in heart failure clinical trials 31
Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides 31
A simple echocardiographic score to rule out cardiac amyloidosis 30
Safety and Tolerability of Neurohormonal Antagonism in Cardiac Amyloidosis 30
sST2 for Outcome Prediction in Acute Heart Failure: Which Is the Best Cutoff? 30
Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets 30
Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient 28
Safety and Efficacy of Amiodarone in a Patient With COVID-19 27
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 26
What Is Hidden Behind Inferior Negative T Waves: Multiple Cardiac Glomangiomas 24
Prognostic value of right ventricular refractory period heterogeneity in Type-1 Brugada electrocardiographic pattern 24
Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy 22
Effects of vericiguat in heart failure with reduced ejection fraction: do not forget sST2. Letter regarding the article ‘Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial’ 22
Monoclonal antibodies and amyloid removal as a therapeutic strategy for cardiac amyloidosis 20
Is targeting cyclic guanosine monophosphate by vericiguat effective to treat ischaemic heart failure with reduced ejection fraction? Yes, it is 19
[Central apneas and cardiovascular diseases] 18
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 18
Valve disease in cardiac amyloidosis: an echocardiographic score 18
Myocardial Infarction Following COVID-19 Vaccine Administration: Post Hoc, Ergo Propter Hoc? 18
Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction 17
Risk Stratification in Transthyretin Cardiac Amyloidosis: The Added Value of Lung Spirometry 16
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 16
Haemodynamic forces predicting remodelling and outcome in patients with heart failure treated with sacubitril/valsartan 15
Stroke in ATTR cardiac amyloidosis: Does only rhythm matter? 14
Cardiovascular toxicity from therapies for light chain amyloidosis 14
RNA-targeting and gene editing therapies for transthyretin amyloidosis 13
[Treatment of cardiac fibrosis: from neurohormonal antagonists to CAR-T cells] 12
Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy 11
Pathophysiological Rationale and Clinical Evidence for Neurohormonal Modulation in Heart Failure with Preserved Ejection Fraction 10
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 9
Sex differences in transthyretin cardiac amyloidosis 9
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 9
Management and treatment of cardiotoxicity due to anticancer drugs: 10 questions and answers 8
Tissue Characterization in Cardiac Amyloidosis 7
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 7
Biomarkers of HFpEF: Natriuretic Peptides, High-Sensitivity Troponins and Beyond 7
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 7
Right heart failure in left heart disease: imaging, functional, and biochemical aspects of right ventricular dysfunction 6
The Journey of Human Transthyretin: Synthesis, Structure Stability, and Catabolism 6
Targeting precipitants to prevent heart failure hospitalization. Does season matter? 4
Head-to-head comparison between recommendations by the ESC and ACC/AHA/HFSA heart failure guidelines 4
Statin therapy in COVID-19 infection 2
Totale 2.336
Categoria #
all - tutte 24.433
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.433


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202096 3 0 2 4 8 14 11 11 14 12 3 14
2020/2021344 26 28 17 27 13 26 22 24 39 24 49 49
2021/2022544 45 67 17 39 25 62 45 94 58 50 7 35
2022/2023563 33 61 23 50 58 71 23 49 103 22 51 19
2023/2024756 43 15 140 74 47 65 53 31 27 47 31 183
2024/202517 17 0 0 0 0 0 0 0 0 0 0 0
Totale 2.336